SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-015906
Filing Date
2022-11-02
Accepted
2022-11-02 07:45:41
Documents
54
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q qure-20220930x10q.htm   iXBRL 10-Q 2060638
2 EX-31.1 qure-20220930xex31d1.htm EX-31.1 15059
3 EX-31.2 qure-20220930xex31d2.htm EX-31.2 15063
4 EX-32.1 qure-20220930xex32d1.htm EX-32.1 14753
  Complete submission text file 0001558370-22-015906.txt   6987160

Data Files

Seq Description Document Type Size
5 EX-101.SCH qure-20220930.xsd EX-101.SCH 37118
6 EX-101.CAL qure-20220930_cal.xml EX-101.CAL 47248
7 EX-101.DEF qure-20220930_def.xml EX-101.DEF 220265
8 EX-101.LAB qure-20220930_lab.xml EX-101.LAB 408478
9 EX-101.PRE qure-20220930_pre.xml EX-101.PRE 309436
48 EXTRACTED XBRL INSTANCE DOCUMENT qure-20220930x10q_htm.xml XML 1170269
Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Filer) CIK: 0001590560 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36294 | Film No.: 221352319
SIC: 2834 Pharmaceutical Preparations